Articles

Judge strikes down rule requiring drug ads to reveal prices

A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The lawsuit was brought by three major manufacturers: Merck, Amgen and Indianapolis-based Eli Lilly.

Read More
harrington-3-2col.jpg

LEADERSHIP IN LAW 2017: Michael J. Harrington

Mike Harrington is one of the top executives at Eli Lilly and Co., rising in the ranks since joining in 1991. He’s been a leader at the company on diversity initiatives and is a champion for ensuring the legal field is a welcoming place for people of all backgrounds. The company has been rated a […]

Read More

Lilly, other drugmakers face federal pricing probe

Indianapolis-based Eli Lilly and Co. and other U.S. drugmakers are being investigated by federal prosecutors over their drug-pricing practices related to Medicare and Medicaid, The Wall Street Journal and Reuters reported Friday.

Read More

Judge dismisses bulk of Christ Church suit against JPMorgan

A federal judge on Thursday dealt a major blow to Christ Church Cathedral’s lawsuit charging JPMorgan Chase & Co. caused $13 million in losses in trust accounts endowed decades ago by Eli Lilly Jr. via “intentional mismanagement” and “self-dealing.”

Read More
focus-bottle-2col.jpg

Bottling up generics

The Supreme Court of the United States recently heard a government challenge of drugmakers’ “pay to delay” practice.

Read More